Modafinil Overview: Current Insights and Advances In Cognitive Enhancement
Modafinil, a wakefulness-selling agent, has garnered significant consideration since its approval by the FDA in 1998 for the treatment of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Over the years, its off-label use as a cognitive enhancer has sparked both interest and debate among researchers, healthcare professionals, and the general public. This review …
Modafinil Overview: Current Insights and Advances In Cognitive Enhancement Read More »